UPDATE 1-Gilead Q2 profit beats Wall Street, 2015 sales outlook raised
July 28, 2015 at 16:45 PM EDT
July 28 (Reuters) - Gilead Sciences Inc said on Tuesday its quarterly net profit rose 32 percent, driven by sales of hepatitis C drugs that beat Wall Street estimates.
